Biological Pathway: Reactome:R-HSA-444473

Formyl peptide receptors bind formyl peptides and many other ligands related metabolites

find 2 related metabolites which is associated with the biological pathway Formyl peptide receptors bind formyl peptides and many other ligands

this pathway object is a organism specific pathway, which is related to taxonomy Homo sapiens (human).

The formyl peptide receptor (FPR) was defined pharmacologically in 1976 as a high affinity binding site on the surface of neutrophils for the peptide N-formyl-methionine-leucine-phenylalanine (fMLF). FPR was cloned in 1990 and the cDNA used as a probe to identify two additional genes, FPRL1 and FPRL2. The three genes for a cluster on 19q13.3. All are coupled to the Gi family of G proteins.
All 3 receptors can be activated by formyl peptides but also display affinities for a range of structurally diverse ligands.

fMLP;N-Formyl-MLF

(2S)-2-[[(2S)-2-[[(2S)-2-formamido-4-methylsulfanylbutanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoic acid

C21H31N3O5S (437.1984)


N-Formyl-Met-Leu-Phe (fMLP; N-Formyl-MLF) is a chemotactic peptide and a specific ligand of N-formyl peptide receptor (FPR). N-Formyl-Met-Leu-Ph is reported to inhibit TNF-alpha secretion.

   

For-Met-Leu-Phe-OH

N-Formyl-L-methionyl-L-leucyl-L-phenylalanine

C21H31N3O5S (437.1984)


N-Formyl-Met-Leu-Phe (fMLP; N-Formyl-MLF) is a chemotactic peptide and a specific ligand of N-formyl peptide receptor (FPR). N-Formyl-Met-Leu-Ph is reported to inhibit TNF-alpha secretion.